A. K. Herbrand

Predicting protein targets for drug-like compounds using transcriptomics

Nicolas A. Pabon, Z. Bar-Joseph, C. Camacho, 2018, bioRxiv.

Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs

L. Hemkens, M. Briel, H. Ewald, 2021, JAMA network open.

Proteome-scale detection of drug-target interactions using correlations in transcriptomic perturbations

Nicolas A. Pabon, Z. Bar-Joseph, C. Camacho, 2018 .

Prediction of RECRUITment In randomized clinical Trials (RECRUIT-IT)—rationale and design for an international collaborative study

M. Meade, D. Cook, J. Ioannidis, 2020, Trials.

Characteristics and survival of patients with cancer with intended off-label use—a cohort study

L. Hemkens, M. Walter, B. Kasenda, 2022, BMJ Open.

Supplemental Information Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK 1 Protein Kinase

F. Gervasio, G. Saladino, P. Alzari, 2016 .

Characteristics and interpretation of subgroup analyses based on tumour characteristics in randomised trials testing target-specific anticancer drugs: design of a systematic survey

G. Guyatt, L. Hemkens, M. Briel, 2020, BMJ Open.